| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T18 |
0-151 |
Sentence |
denotes |
Ruscitti et al. [2] also comment on the potential adverse role of IL-6 on lymphocyte mediated performin killing as summarized by Cunningham et al. [1]. |
| T19 |
152-528 |
Sentence |
denotes |
Ruscitti et al. [2] prefer the “cytokine storm syndrome” over macrophage activation syndrome (MAS) and indeed we used the “cytokine storm syndrome” terminology within our article but went with “MAS-like” terminology overall As summarized above, we introduced a new concept for MAS classification as gain or loss in immune function that is very relevant for COVID-19 infection. |
| T20 |
529-646 |
Sentence |
denotes |
We also introduced the concept of a pulmonary intravascular coagulopathy secondary to the pulmonary MAS-like changes. |
| T21 |
647-724 |
Sentence |
denotes |
This is distinct from the disseminated intravascular coagulation seen in MAS. |
| T22 |
725-894 |
Sentence |
denotes |
The abundant monocytes and macrophages in the coronavirus family members like COVID-19 pneumonia certainly do not detract from the use of the terminology “MAS-like” [8]. |
